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Asthma is a chronic inflammatory disorder associated with airway hyper-responsiveness. Al-
though a number of studies have investigated asthma at the molecular level, the molecular
immune signatures associated with asthma severity or with the response to corticosteroids
are still being unraveled. The present study integrated four asthma-related gene expression
datasets from the Gene Expression Omnibus and identified immune-gene signatures asso-
ciated with asthma development, severity, or response to treatment. Normal and mild asth-
matic patients clustered separately from the severe asthma group, suggesting substantial
progression-related changes in gene expression. Pathway analysis of up-regulated severe
asthma-related genes identified multiple cellular processes, such as polymorphism, T-cell
development, and transforming growth factor-β signaling. Comparing gene expression pro-
files of bronchoalveolar lavage cells in response to corticosteroid treatment, showed sub-
stantial reductions in genes related to the inflammatory response, including tumor necrosis
factor signaling in the corticosteroid sensitive versus resistant patients, suggesting a de-
fective immune response to corticosteroids. The data highlight the multifactorial nature of
asthma, but revealed no significant overlap with the gene expression profiles from different
datasets interrogated in current studies. The presented profile suggests that genes involved
in asthma progression are different from those involved in the response to corticosteroids
and this could affect the clinical management of different groups of patients with asthma.
Introduction
Asthma is a chronic inflammatory disorder characterized by reversible airway obstruction and hyperre-
sponsiveness [1]. Asthma can be a long-lasting inflammation since childhood or a disease that develops
later in life. Many patients will have a genetic predisposition to developing asthma. Allergen exposure can
cause an inflammatory conditionmediated by a complex interaction between innate and adaptive immune
cells. The initial description of asthma involves identifying clinical, physiological, and cellular parameters.
Clinical characteristics include age at asthma onset, allergen type, family history, or even the degree of air-
way obstruction; the familiar physiological features, such as wheezing, shortness of breath, and coughing;
and cellular parameters [2]. These characteristics alone are not enough to identify the importance of a
specific pathological process or improve the treatment of patients with asthma.
Asthma remains a major health problem because it is currently one of the most common chronic disor-
ders worldwide [3]. The prevalence of asthma varies in different geographical locations, with the highest
prevalence in countries such as Australia (21.5%), Sweden (20.2%), U.K. (18.2%), Netherlands (15.3%),
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and Brazil (13.0%). The global prevalence of diagnosed asthma in adults has been estimated as 4.3%, ranging from
0.2% inChina to 21.0% in Australia [4,5]. Although asthma prevalence is higher in developed countries, the incidence
of asthma in developing countries is increasing [6].
Previous literature reviews revealed more than 120 and 150 genes that were related to asthma in human and animal
models, respectively [7,8]. These findings indicated that asthma is a polygenic disease and its intricacy originates from
interactions between several genes and environmental factors. This interaction leads to consecutive changes in the
airway microenvironment, starting with the stimulation of inflammatory pathways and recruitment of immune cells
that are not usually present in the airway, leading to bronchoconstriction, airway hyper-responsiveness, and airway
remodeling [7]. The advantage of gene analysis is that it allows the detection of asthma at an early stage and helps
to predict disease progression [9]. Therefore, primarily analyzing several publicly available studies related to gene
expression changes in mononuclear cells could allow a more global view of the changes in the expression of genes
related to mononuclear cells in asthma. Monocytes play an important role in immune and inflammatory diseases,
and while they have not been identified as key players in asthma, they are likely to be pro-inflammatory, be readily
recruited to tissues, and have amajor role in the exacerbation of the disease. Allergens, one of themain factors that can
trigger and exacerbate asthma, include a wide range of indoor allergens, such as dust mites, cockroaches, fungi, and
furred animals; and outdoor allergens, such as pollens and molds. In the present study, we analyzed several publicly
available gene expression datasets related to asthma and identified differential gene signatures that are associatedwith
asthma progression and those that are related to the response to corticosteroids.
Materials and methods
Microarray data analysis
Usingmonocyte and asthma search terms and limited toHomo sapiens studies, the GSE27876, GSE7368, GSE19301,
and GSE40240 raw gene expression datasets were retrieved from the Gene Expression Omnibus GEO, based on the
inclusion/exclusion criteria (peripheral blood mononuclear cells, expression profiling experiment type, and patients
with asthma) and were imported into GeneSpring 13.0 software (Agilent Technologies, Palo Alto, CA, U.S.A.). Raw
data were subsequently normalized using the percentile shift, and a 2.0 (for GSE27876 and GSE7368) and 1.5 (for
GSE19301 and GSE40240) fold-change (FC) cutoff, and P<0.05 were used to determine significantly changed tran-
scripts between groups. Details of the fours datasets included in the present study are listed in Table 1. Clinical data
associated with patients from those studies have been described previously [10,12,13].
Statistical analysis
Pathway analyses were conducted using the Database for Annotation Visualization and Integrated Discovery
(DAVID) functional annotation and clustering bioinformatics tool, as described in our previous report [14]. Sta-
tistical analyses and graphing were performed using GraphPad Prism 6.0 software (GraphPad Software, San Diego,
CA, U.S.A.).
Results
Identiﬁcation of the gene signature associated with asthma progression
First, we analyzed the GSE27876 series comparing peripheral blood cells from mild and severe asthma that were se-
lected from patients classified into the asthma treatment step 4, based on the criteria described in the Global Initiative
for Asthma (GINA) (in the present study the selected severe asthma patients had medication records of high-dose
steroid inhalation with no oral medicine) compared with those from normal subjects [10]. Using a 2-fold change
cut-off, gene expression data analysis revealed 311 differentially expressed mRNA transcripts across all samples. Hi-
erarchical clustering based on the differentially expressed mRNAs revealed clear separation of the severe from the
mild and the mild asthmatic from the normal control group (Figure 1A). Interestingly, we observed that the normal
and mild asthma groups clustered together while the severe asthma group clustered away from the other two groups
(Figure 1A). Further analysis revealed 24 up-regulated and 11 down-regulated genes in patients with mild asthma
compared with normal individuals (Figure 1B,C). Further differentially expressed genes were detected in patients
with severe asthma, with 137 up-regulated and 69 down-regulated genes compared with normal individuals (Figure
1B,C). Further analysis revealed the up-regulation of 121 genes and down-regulation of 35 genes in patients with
severe compared with mild asthma (Figure 1B,C). When comparing the differentially expressed genes in severe ver-
sus control and severe versus mild asthma groups, 100 genes were found to be up-regulated, while 30 genes were
down-regulated (Figure 1B,C; Tables 2 and 3). Interestingly, 18 genes were found to be up-regulated in the severe ver-
sus normal, mild versus normal, and severe versus mild comparisons (Figure 1B,C and Table 2). There were common
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Figure 1. Identiﬁcation of the gene signature associated with asthma development
GSE27876 series: (A) Hierarchical clustering based on differentially expressed mRNAs for patients with mild, moderate, and severe
asthma. (B and C) Comparisons of the up-regulated and down-regulated genes between Mild (M) or Severe (S) versus Normal
(N), and Mild versus Severe. (D) Functional interpretation of the 118 up-regulated genes related to asthma severity. (E) Functional
interpretation of the 31 down-regulated genes related to asthma severity, and enrichment in six categories.
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License 4.0 (CC BY).
3
Bioscience Reports (2018) 38 BSR20180548
https://doi.org/10.1042/BSR20180548
Table 1 Details of the four datasets included in the present study
Series Title/Link Experiment type Experiment design Investigation
GSE27876 In vivo and in vitro study of
asthma
http:
//www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE27876
(Lee et al., 2012)
Expression proﬁling by array To induce an inﬂammatory
response, for in vitro study,
THP1 cells were stimulated for
24 h with LPS or HDM extract.
After stimulation, THP1 cells
were harvested for total RNA
extraction. Total RNA was
extracted from the buffy coat
fractions and RNA was reverse
transcribed into cDNA for
microarray analysis.
Analysis of gene expression
patterns of peripheral blood cells
from asthma patients compared
with those from normal subjects
using microarray analyses.
GSE19301 Gene expression patterns in
peripheral blood mononuclear
cells associated with asthma
exacerbation attack
http:
//www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE19301
(Bjornsdottir et al., 2011)
Expression proﬁling by array PBMCs collected during (a) quiet
(N = 394 samples from 118
subjects), (b) exacerbation (N =
166 samples from 118
subjects), and (c) follow-up (N =
125 samples from 102 subjects).
Gene expression changes in
PBMCs associated with asthma
exacerbations over the course of a
year. Gene expression levels
during stable asthma,
exacerbation, and 2 weeks after an
exacerbation were compared.
GSE7368 Corticosteroid resistant asthma
is associated with classical
activation of airway
macrophages and exposure to
LPS
http:
//www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE7368
Expression proﬁling by array Asthmatics had a baseline
FEV1% predicted of 55–85%,
asthmatic patients were deﬁned
as CS if they had an increase in
FEV1% predicted of greater than
15% after a 1-week course of
prednisone, and as CR if less
than 12% change in FEV1%
predicted was observed.
Gene microarray analysis was
performed with bronchoalveolar
lavage (BAL). The cause of
corticosteroid resistant (CR)
asthma is unknown. Gene
microarray technologies have the
potential to substantiate new
hypotheses regarding the etiology
of corticosteroid resistance.
GSE40240 Allergen inhalation challenge
effect on peripheral blood of
asthmatic early responders (ERs)
and dual responders (DRs)
(Singh et al., 2013)
Expression proﬁling by array Blood was collected immediately
prior to, and 2 hours after
challenge. The change in gene
expression (post-expression
minus pre-expression) in ERs
was compared with the change
in gene expression in DRs using
age and sex as covariates.
Analysis of blood collected from
asthmatics immediately prior to,
and 2 hours after, cat allergen
challenge. Some asthmatics are
early responders while others are
dual (early plus late) responders.
genes between these two study groups, where five genes were up-regulated (ATP5E,BRK1,KCNJ6,RNASEH2C, and
RPL9) and one gene (RAB5B) was down-regulated in patients with mild and severe asthma compared with normal
individuals (Tables 2 and 3). Functional annotation using the DAVID gene functional classification tool conducted
on the 118 up-regulated genes related to asthma severity revealed multiple enriched functional categories, includ-
ing polymorphism, T-cell development, and transforming growth factor-β (TGF-β) signaling (Figure 1D). The most
highly enriched functional category was polymorphism. Functional annotation conducted on the 30 down-regulated
genes related to asthma severity identified significant enrichment in six categories (Figure 1E).
Identiﬁcation of gene signatures associated with corticosteroid
sensitivity
We subsequently analyzed the GSE7368 series comparing bronchoalveolar lavage (BAL) cells from corticosteroid
resistant (CR) and corticosteroid sensitive (CS) patients with asthma. The cells consisted mainly of macrophages,
neutrophils, and lymphocytes. Patients were defined as CS if they had an increase in forced expiratory volume 1
(FEV1) predicted (which is defined as the FEV1 of the patient divided by the average FEV1 in the population for
any person of similar age, sex, and body composition) of greater than 15% after a 1-week course of prednisone, and
as CR if a less than 12% change in FEV1 predicted was observed [11]. Hierarchical clustering based on differentially
expressedmRNAs (2.0 FC) revealed clear separation of theCR from theCS groups (Figure 2A). Further analysis iden-
tified 70 up-regulated and 16 down-regulated genes in the CR patients compared with the CS patients (Table 4). The
up-regulated genes were further classified based on functional clustering using DAVID. BAL cells from CS patients
showed significant enrichment in several pathways related to inflammatory responses, such as tumor necrosis factor
(TNF) signaling pathways, inflammatory responses, cytokines, immune responses, chemokines, interleukin-8-like
domain, and the nuclear factor kappa B (NF-κB) signaling pathway (Figure 2B).
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Table 2 Common up-regulated genes between different asthmatic groups from the GSE27876 dataset
(a) List of the common up-regulated genes between the severe versus normal and severe versus mild groups
ACSM2A ADCYAP1 ANKRD20A2 ARCN1 BOLL
CAMK1G COL25A1 COL3A1 CPA2 CPLX1
CYP19A1 DCST2 DIO1 DMD DPY19L2P2
DYDC2 DYRK3 ECT2 EEF1E1 EFCAB11
EFHB ERVW-1 ESR1 ESRRG EYA1
FAM131C FAM170A FGF20 FNDC7 FZD5
GDF9 GDNF GJA3 GJA5 GLI3
GNRH2 GPR115 GRIK2 GULP1 GUSBP3
HOXC12 IKZF4 KNCN KRTAP4-1 LCA5L
LINC00466 LINC01133 lnc-ARSJ-1 lnc-FAM lnc-PPIAL4G-9
lnc-PTN-2 LOC101060510 LOC101929315 MAP7D2 MAP9
MARK2 MOB3B MTIF2 NAPG NPAS2
NPR3 NUCKS1 OGG1 PCDH7 PINK1-AS
PPIC PPP1R16A RAB39B RAG1 RPL23A
RPS27 RRP15 RUNX2 RWDD4 SEZ6
SIAE SKIL SLC19A3 SLC26A7 SNAPC4
SPAG16 SPTA1 SPX TARID TDRD5
TENM3 TGM2 TMEM213 TPT1 TRIM42
UBE2S VSNL1 VTA1 XKRY2 XLOC l2
YAP1 ZDHHC13 ZNF385B ZNF396 ZNF562
(b) List of the common up-regulated genes between the severe versus normal, mild versus normal, and severe versus mild groups
ACVR2B AKR1B10 ANXA8L1 BMPR1A CADPS
CFH FAM110D FAM74A6 HS3ST5 JAM2
KLK7 LOC101927000 MYOM3 P2RX6P RBMS3
SORBS1 SPIN1 TFF1
(c) List of the common up-regulated genes between the severe versus normal and mild versus normal groups
ATP5E BRK1 KCNJ6 RNASEH2C RPL9
Table 3 Common down-regulated genes between different groups of patients with asthma from the GSE27876 dataset
(a) List of the common down-regulated genes between the severe versus normal and severe versus mild groups
ALG3 BLOC1S5 C10orf95 CRLF3 DEXI
ELAC2 FBL IPO5P1 KDM5B lnc-AC040934.1-3
LOC155060 LOC440311 LRRC37A4P MRPS34 MYO15B
NME6 PDPR PURA RAB4B RARRES3
RNF157 RPS6KA5 RPTOR SERGEF SIGIRR
SNTA1 SRSF6 SUFU TMEM186 ZMYM6
(b) List of the common down-regulated genes between the severe versus normal, mild versus normal, and severe versus mild groups
SPOCK2
(c) List if the common down-regulated genes between the severe versus normal and mild versus normal groups
RAB5B
Identiﬁcation of gene signature associated with asthma exacerbation
To identify the gene signature associated with asthma exacerbation, the GSE19301 series comparing the gene ex-
pression profile in peripheral blood mononuclear cells (PBMCs) associated with an asthma exacerbation attack was
analyzed. For the GSE19301 series, samples were collected while the subjects were experiencing one or more of the
following symptoms: increases in wheezing, chest tightness, and/or shortness of breath.Gene expression levels during
stable (quiet) asthma, exacerbation, and 2weeks after an exacerbationwere compared [12]. The commonup-regulated
genes between ‘Exacerbation versusQuiet’ and ‘Exacerbation versus Follow-up’were the genes that encode interferon
α-inducible protein 27 (IFI27) and interferon-induced protein 44 Like (IFI44L) [15] (Figure 2C). Down-regulated
genes were only observed in the ‘Exacerbation versus Follow-up’ group, and they were lactotransferrin (LTF) and the
defensin α 1 family (DEFA1, DEFA1B, and DEFA).
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Figure 2. Identiﬁcation of the gene signature associated with asthma exacerbation
GSE7368 series: (A) Hierarchical clustering based on differentially expressed mRNAs in response to corticosteroids. (B) Functional
interpretation of the 70 up-regulated genes related to corticosteroid resistance. (C) The common up-regulated genes between
GSE19301 series groups; EX, exacerbation; FU, follow-up; Q, quiet.
Identiﬁcation of the gene signature associated with early versus dual
responders to inhalers
To identify the gene signature that could discriminate early from late responders to inhalers, the GSE40240 series
comparing the peripheral blood cell gene expression profile from asthmatic early responders (ERs) to dual (early plus
late) responders (DRs) following allergen inhalation challenge was analyzed. Study participants were classified as ERs
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Table 4 Differentially expressed genes related to corticosteroid resistance from the GSE7368 study
(a) List of the up-regulated genes in the corticosteroid resistance versus the corticosteroid sensitive groups
CCL3L3 AC079305.10 ADM AKAP2 BPIFB1
CAHM CCL20 CCL3 CCL4 CD2
CHI3L1 CTA-29F11.1 CXCL1 CXCL2 CXCL3
DUSP2 EGR1 EIF4E EPC1 FAM46C
FOSB GBP2 GPX3 HSPA1A ICAM1
IER2 IER3 IL1α IL1β IL6
IL8 KLF6 KLRB1 LBH LINC00936
LOC100129518 LOC100506098 LOC101060267 LPXN MT1G
MT1H MT1X NFKBIA NFKBIE NFKBIZ
NFKBIZ NR4A1 OTUD1 PADI2 PERP
PHLDA1 PIGR PLEKHA5 PMAIP1 PPP1R15A
PPP1R15A PSD3 RABGAP1L SCGB1A1 SERPINB3
SERPINB3 SLPI SNORD3A TACSTD2 THAP2
TMC5 TMEM107 TNF TNFAIP3 TRA2B
ZFP36L1
(b) List of the down-regulated genes in the corticosteroid resistance versus the corticosteroid sensitive groups
ABHD2 BCAT1 CBS CCL24 CDKN1B
DENND4C HHEX IRAK3 IREB2 NXPE3
PAG1 PKN2 RPS24 SH3PXD2B SOCS1
TMEM170B
Table 5 Differentially expressed genes between early (ER) and dual responders (DR) from the GSE40240 dataset
(a) List of the common up-regulated genes between ‘up post DR versus post ER’ and ‘up pre DR versus pre ER’ group
C12orf57 CAMK4 CCR7 GCNT4 ITGA6
ITM2A LEF1 LOC100134091 MAL RPL30
RPL41 RPL4P4 THEMIS TRABD2A VSIG1
ZNF83
(b) List of the common up-regulated genes between ‘up post DR versus pre DR’ and ‘up post ER versus pre ER’
MME
(c) List of the common down-regulated genes between ‘down post DR versus post ER’ and ‘down pre DR versus pre ER’ groups
LILRA3 CYP1B1 PI3 PISD|MIR7109 TREML4
(d) List of the common down-regulated genes between ‘down post DR versus pre DR’ and ‘down post ER versus pre ER’
DDIT4
Abbreviations: DR, dual responders; ER, early responders.
if the initial drop in FEV1 resolved back to baseline within 1–3 h of allergen inhalation and if the maximum drop in
FEV1 between 3 and 7 hours was less than 15%. Study participants were classified as DRs if, in addition to the early
response, the participants experienced a maximum drop in FEV1 of 15% or greater between 3 and 7 h of allergen
inhalation. In this series, blood samples were collected from 28 subjects immediately before and 2 h after challenge,
and the changes in gene expression (post-exposure versus pre-exposure) in ERs were compared with the changes
in gene expression in DRs, using age and sex as covariates [13]. Analysis of basal gene expression before inhalation
challenge identified 32 genes that were up-regulated in the DR compared with the ER group. Interestingly, 2 h after
challenge, only 16 out of the 32 genes were still elevated in the DR versus ER group. Sixteen additional genes were
also up-regulated in the post-exposure DR versus post-exposure ER groups (Figure 3A and Table 5). By contrast,
31 genes were down-regulated immediately before allergen challenge in the DR group compared with the ER group.
However, 2 h later, only five genes were still down-regulated and an additional nine genes became down-regulated in
the DR compared with the ER groups (Figure 3B and Table 5). In the DR group post-allergen challenge, three genes
were up-regulated and two genes were down-regulated compared with pre-allergen challenge (Figure 3A,B), while
in the ER group post-allergen challenge, one gene was up-regulated and three genes were down-regulated compared
with before allergen challenge. In the present study, the direct response to allergen challenge led to up-regulation
of 32 genes in the DR group compared with the ER group. Conducting functional clustering on these genes using
DAVID showed enrichment in many categories. Most of the pathways were not related to inflammatory responses
except for three categories: cellular response to IL-4, cellular response to cytokine stimulus, and cellular response to
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Identiﬁcation of the gene signature associated with early versus dual responders to inhalers
GSE40240 series. (A and B) The common up-regulated and down-regulated genes between the GSE40240 series groups. (C)
Functional interpretation of the 32 up-regulated genes related to immediate response following allergen challenge. (D) Functional
interpretation of the 32 up-regulated genes related to a delayed response following allergen challenge; pstDR, post dual responders;
pstER, post early responders; preDR, pre dual responders; preER, pre early responders.
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inflammation (Figure 3C). Similar findings were observed in the delayed response. The functional classification of the
32 up-regulated genes in the DR group compared with the ER group after 2 h of allergen response showed that these
down-regulated genes were associated with different signaling pathways; some of them were related to inflammation
and the adaptive immune response (Figure 3D).
Discussion
In the present study, we interrogated several publicly available datasets and identified differentially expressed genes in
immune cells correlating with asthma, severity, response to allergens, and response to corticosteroid treatment. Our
analysis revealed a large number of genes that were either up-regulated or down-regulated in patients with asthma
in comparison with the control group or other groups of patients that were also investigated within the same study,
depending on the study design. While each dataset revealed distinct gene expression patterns, we observed minimal
overlap among the different studies. This was not surprising because each study dealt with a different aspect of asthma
(such as asthma progression versus response to corticosteroid treatment). Additionally, it is plausible that several of
the observed differences may also due to the different experimental design of the databases studied: The kind of
material analyzed (BAL and PMCs) and size of the samples studied. Therefore, our data suggested that asthma is a
multifactorial disease where distinct factors can be engaged in the development of asthma, its severity, or the response
to treatment.
In the GSE27876 dataset, changes in gene expression in patients with mild and severe asthma compared with
normal individuals were assessed and revealed clear associations between changes in gene expression and asthma
severity. More genes correlating with asthma severity were up-regulated than down-regulated. Interestingly, patients
with mild asthma did not have as many changes in gene expression when compared with normal controls. While few
of these deregulated genes were common between patients with mild and severe asthma, more affected genes were
observed with asthma severity. However, when the patients with severe asthma were compared with normal individ-
uals or patients with mild asthma, the differentially expressed genes were mostly the same for both groups, which
implied that changes in gene expression are mostly affected by severity. Functional annotation of the differentially
expressed genes in patients with severe asthma highlighted a plausible role for genes related to polymorphism, T-cell
development, and TGF-β signaling in the severity of asthma. Relatively recent study has reported a single nucleotide
polymorphism rs848 in the IL13 gene region that was significantly associated with asthma severity in patients that
were lifetime physician-diagnosed as asthmatic in Italy [16].
The aim of the GSE7368 study was to compare the changes in gene expression between the CR and the CS asthma
patients in response to corticosteroid treatment. The level of change in gene expression in the present study corre-
lated with CR; in addition, more genes were up-regulated than down-regulated in the CR patients compared with
the CS patients. This finding implied that the CR patients did not respond to corticosteroid treatment. A number of
studies have linked steroid resistance in asthma to defects in glucocorticoid receptor (GR) expression and activity,
including reduced GR expression, reduced GR binding affinity to glucocorticoids and/or glucocorticoid response el-
ements GREs, and elevated expression of pro-inflammatory transcription factors. Increased expression of IL-2, IL-4,
and IL-13 in the airways of asthmatics can induce local steroid insensitivity by reducing GR binding affinity in T cells
[17]. Immune cells from CR patients expressed more changes at the gene level as a result of an inadequate response
to treatment. The data showed up-regulation of several genes related to the TNF signaling pathway, inflammatory
response, cytokines, immune response, chemokine interleukin-8-like domain, and the NF-κB signaling pathway. In-
terestingly, we observed that TNF and inflammatory responses were among the top enriched pathways in patients
who are resistant to corticosteroid treatment. Our data suggested that in the resistant patients, signaling via the cor-
ticosteroid pathway is defective; therefore, signaling through the TNF and inflammatory pathways remained active
and were not suppressed in those patients. TNF was found to be involved in the development of allergic diseases,
particularly asthma [18]. TNF-α is unlikely to be detected in healthy individuals; however, elevated levels in serum
and tissue were found in inflammatory and infectious conditions [19,20]. Monocytes are an important source of TNF
[21]. In addition, chemokines secreted by monocytes, e.g. CXCL2 [22], or chemoattractants for monocytes, CCL4
[23], were both elevated in CR, implying a plausible role of monocytes in the pathology of asthma.
The GSE19301 dataset compared gene expression changes in PBMCs during stable asthma, exacerbation, and 2
weeks after exacerbation (follow-up). At the onset of asthma exacerbation, only two genes were up-regulated com-
pared with the stable state of asthma; 2 weeks later an additional three genes were up-regulated. Examining changes
in the gene expression in the follow-up samples showed up-regulation of ten genes in PBMCs compared with sta-
ble asthma. Therefore, asthma exacerbation leads to changes in gene expression, whether immediately or 2 weeks
later, compared with the stable state of asthma. Both of the common up-regulated genes, IFI27 that is expressed by
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
9
Bioscience Reports (2018) 38 BSR20180548
https://doi.org/10.1042/BSR20180548
monocytes [24], and IFI44L, are interferon-response genes [25], and are thus inflammation-related genes [26,27].
However, the down-regulated gene encodes LTF, which exhibits an anti-inflammatory activity through its ability to
inhibit eosinophil migration and regulates cellular growth and differentiation [28]. In addition, defensins are a family
of antimicrobial and cytotoxic peptides involved in host defense that are expressed predominantly in neutrophils and
epithelial cells [29], implying that asthma exacerbation induces an ongoing inflammatory response.
In the last study (GSE40240), the effect of allergen inhalation challenge on peripheral blood from asthmatic early
responders and dual responders was assessed using gene expression analysis of blood collected from patients with
asthma immediately before, and 2 hours after, cat allergen challenge. The findings of the present study implied a
stronger effect of allergen exposure on dual responders compared with that in early responders because they exhib-
ited more changes in gene expression immediately before, and 2 hours after, allergen exposure. In addition, more
up-regulated genes were observed in the present study, which was compatible with the allergen challenge response
strength. As time passed after the allergen challenge, fewer genes remain down-regulated, indicating that time affects
the down-regulated genes more than the up-regulated genes.
In conclusion, our data unraveled gene signatures and signaling pathways in mononuclear cells correlating with
asthma, severity, response to allergens, and response to corticosteroid treatment. Our data also highlight the multi-
factorial nature of asthma, and suggests that genes involved in asthma progression are different from those involved
in the response to corticosteroids, with potential implications in the clinical management of different groups of asth-
matic patients.
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